Alpha vs. Beta Receptor Effects - Pharmacology

1. In an experiment, two adrenergic agonists are infused intravenously. Drug X causes a marked increase in heart rate and cardiac output but a significant decrease in total peripheral resistance. Drug Y causes a potent increase in total peripheral resistance and blood pressure, accompanied by a decrease in heart rate. Which of the following correctly identifies the drugs?
   Answer: Drug X is isoproterenol; Drug Y is phenylephrine. Drug X's profile matches isoproterenol, a non-selective $\beta$-agonist. It stimulates $\beta_1$-receptors to increase heart rate and cardiac output, and $\beta_2$-receptors to cause vasodilation and decrease peripheral resistance. Drug Y's profile matches phenylephrine, a pure $\alpha_1$-agonist. It causes intense vasoconstriction, increasing peripheral resistance and blood pressure, which in turn triggers a reflex bradycardia (decrease in heart rate).
2. A patient with open-angle glaucoma is prescribed brimonidine ophthalmic drops. The medication effectively lowers intraocular pressure by decreasing the production of aqueous humor from the ciliary epithelium. This therapeutic effect is achieved through agonism of which specific receptor subtype?
   Answer: $\alpha_2$-receptors, which inhibit adenylyl cyclase and reduce aqueous humor formation. Brimonidine is a selective $\alpha_2$-adrenergic agonist. In the eye, $\alpha_2$-receptors are located on the ciliary body epithelium. Their stimulation activates an inhibitory G-protein (Gi), which leads to the inhibition of adenylyl cyclase, a decrease in cAMP levels, and a subsequent reduction in the rate of aqueous humor production. This action lowers intraocular pressure.
3. A 31-year-old woman in preterm labor at 30 weeks gestation is administered an intravenous tocolytic agent. The drug successfully reduces the frequency and intensity of her uterine contractions. However, the patient's heart rate increases from 85 bpm to 120 bpm. This side effect is most likely due to the drug's agonist activity on which receptor?
   Answer: $\beta_1$-receptors, due to either direct stimulation or spillover from the primary target. Tocolytic agents used for preterm labor, such as terbutaline, are $\beta_2$-adrenergic agonists. Their therapeutic effect is to stimulate $\beta_2$-receptors on uterine smooth muscle, causing relaxation (tocolysis). However, these drugs are not perfectly selective. They can also stimulate $\beta_1$-receptors, which are the predominant beta-receptor subtype in the heart. Stimulation of cardiac $\beta_1$-receptors leads to a direct increase in heart rate (tachycardia) and contractility.
4. A 17-year-old with exercise-induced asthma uses an albuterol inhaler. Albuterol is considered a selective $\beta_2$-adrenergic agonist. After using several puffs in a short period, he reports feeling palpitations and a tremor. The palpitations are best explained by which of the following pharmacological principles?
   Answer: Albuterol's selectivity is relative, and at high concentrations, it can stimulate cardiac $\beta_1$-receptors. Drug selectivity is often dose-dependent. While albuterol has a higher affinity for $\beta_2$-receptors (mediating bronchodilation), it retains some affinity for $\beta_1$-receptors. At high doses or with significant systemic absorption, albuterol can bind to and stimulate $\beta_1$-receptors in the sinoatrial node and myocardium, directly causing tachycardia and palpitations. While a minor reflex tachycardia (distractor C) might occur, the direct off-target stimulation is the more significant mechanism.
5. An experimental drug is a full agonist at both $\alpha_1$ and $\beta_2$ adrenergic receptors with similar high affinity. When infused intravenously into a healthy volunteer, which of the following hemodynamic profiles is the most likely to be observed?
   Answer: Increased systolic pressure, decreased diastolic pressure, and relatively unchanged mean arterial pressure. Stimulation of $\alpha_1$-receptors causes widespread vasoconstriction, which tends to increase both systolic (SBP) and diastolic blood pressure (DBP). Concurrently, stimulation of $\beta_2$-receptors causes vasodilation in skeletal muscle beds, which tends to decrease DBP. The net effect is often an increase in SBP (due to vasoconstriction increasing afterload and potential reflex cardiac stimulation) and a decrease in DBP (due to $\beta_2$-mediated vasodilation). Because mean arterial pressure (MAP) is calculated as DBP + 1/3(SBP-DBP), these opposing effects can result in a relatively unchanged MAP.
6. A 58-year-old patient with type 2 diabetes and hypertension is treated with a non-selective beta-blocker. This medication poses a risk of masking the symptoms of hypoglycemia. The blockade of which receptor is primarily responsible for masking the key symptom of tachycardia during a hypoglycemic episode?
   Answer: Blockade of cardiac $\beta_1$-receptors, preventing the compensatory increase in heart rate. During hypoglycemia, the body initiates a sympathetic response, releasing epinephrine and norepinephrine. These catecholamines normally stimulate cardiac $\beta_1$-receptors, causing tachycardia, which is a key warning sign for the patient. A non-selective beta-blocker (or even a cardioselective one) will block these cardiac $\beta_1$-receptors, thus preventing the tachycardic response and 'masking' this important symptom of hypoglycemia. While $\beta_2$ blockade does impair glucose recovery (distractor A), it doesn't mask the symptom of tachycardia.
7. For the urinary bladder to properly fill and store urine (the continence phase), the autonomic nervous system must coordinate muscle activity. Which combination of adrenergic receptor actions correctly describes the sympathetic contribution to this process?
   Answer: Agonism of $\beta_2$/$\beta_3$-receptors causing detrusor relaxation and $\alpha_1$-receptors causing sphincter contraction. Sympathetic activity promotes urine storage. This is achieved by two main adrenergic actions: 1) Relaxation of the large bladder wall muscle (the detrusor), which is mediated primarily by $\beta_3$-receptors (and to a lesser extent $\beta_2$-receptors). 2) Contraction of the smooth muscle at the bladder base and internal urethral sphincter, which increases outlet resistance. This contraction is mediated by $\alpha_1$-receptors.
8. Sympathetic stimulation of the juxtaglomerular (JG) apparatus in the kidney is a key mechanism for increasing blood pressure via the renin-angiotensin-aldosterone system. The release of renin from JG cells is directly mediated by the activation of which adrenergic receptor?
   Answer: $\beta_1$-receptors located on the JG cells themselves. The juxtaglomerular (JG) cells of the kidney are directly innervated by sympathetic nerves. These cells prominently express $\beta_1$-adrenergic receptors. When norepinephrine is released from sympathetic nerves, it binds to these $\beta_1$-receptors, activating a Gs-coupled pathway that increases cAMP and stimulates the synthesis and release of renin into the bloodstream. This is a major reason why $\beta_1$-blockers are effective antihypertensive agents.
9. An anesthesiologist administers a low-dose intravenous infusion of epinephrine. This intervention is expected to increase systolic blood pressure while simultaneously decreasing diastolic blood pressure. The observed decrease in diastolic blood pressure is primarily mediated by epinephrine's agonist activity at which receptor?
   Answer: $\beta_2$-receptors in the vasculature of skeletal muscle, causing significant vasodilation. At low doses, epinephrine's effects on $\beta_2$-receptors are prominent. Stimulation of $\beta_2$-receptors in the vasculature supplying skeletal muscle causes vasodilation, which decreases total peripheral resistance (TPR). Since diastolic blood pressure is largely dependent on TPR, this vasodilation leads to a fall in diastolic pressure. The increase in systolic pressure is due to $\beta_1$-mediated increases in heart rate and contractility.
10. A new sympathomimetic amine is characterized and found to cause a potent, dose-dependent increase in systolic and diastolic blood pressure, a decrease in heart rate, and contraction of the pupillary dilator muscle. Based on this profile, the drug most likely has selective agonist activity at which receptor?
    Answer: $\alpha_1$-adrenergic receptors This profile is classic for a pure $\alpha_1$-adrenergic agonist. Stimulation of $\alpha_1$-receptors on vascular smooth muscle causes vasoconstriction, increasing both systolic and diastolic blood pressure. The significant rise in blood pressure triggers a baroreceptor-mediated reflex bradycardia (decrease in heart rate). Stimulation of $\alpha_1$-receptors on the pupillary dilator muscle causes mydriasis (pupil dilation).
11. A patient in the intensive care unit receives a continuous infusion of a pure $\alpha_1$-adrenergic agonist (e.g., phenylephrine) for hypotension. While mean arterial pressure increases from 60 mmHg to 95 mmHg, the heart rate paradoxically decreases from 115 bpm to 80 bpm. This decrease in heart rate is best explained by which physiological mechanism?
    Answer: A baroreceptor-mediated reflex increase in parasympathetic (vagal) outflow to the heart. Pure $\alpha_1$-agonists cause intense vasoconstriction, leading to a significant increase in blood pressure. This sharp rise in pressure is sensed by baroreceptors in the carotid sinus and aortic arch. In response, the central nervous system initiates a reflex arc that increases vagal (parasympathetic) tone and decreases sympathetic tone to the heart. The increased vagal activity, mediated by acetylcholine at the SA node, slows the heart rate. This is known as reflex bradycardia.
12. Anaphylactic shock is characterized by massive histamine release, leading to bronchoconstriction and vasodilation. Epinephrine is the treatment of choice. The life-saving reversal of bronchoconstriction is mediated by $\beta_2$-receptors. Which intracellular signaling cascade is initiated by $\beta_2$-receptor stimulation in bronchial smooth muscle?
    Answer: Activation of adenylyl cyclase, increasing intracellular cyclic AMP (cAMP). All $\beta$-adrenergic receptors ($\beta_1$, $\beta_2$, $\beta_3$) are coupled to a stimulatory G-protein (Gs). When an agonist like epinephrine binds, Gs activates the enzyme adenylyl cyclase. Adenylyl cyclase catalyzes the conversion of ATP to cyclic AMP (cAMP). In bronchial smooth muscle, increased cAMP levels activate protein kinase A (PKA), which then phosphorylates various proteins, leading to sequestration of intracellular calcium and ultimately, muscle relaxation (bronchodilation).
13. A patient is administered an ophthalmic solution to induce mydriasis (pupil dilation) for a retinal exam. The drug works by stimulating the radial muscle of the iris to contract. This pharmacological action is characteristic of an agonist for which receptor?
    Answer: $\alpha_1$-adrenergic receptor The iris contains two sets of muscles that control pupil size. The sphincter pupillae (circular muscle) is innervated by the parasympathetic system and causes constriction (miosis) via M3 receptors. The dilator pupillae (radial muscle) is innervated by the sympathetic system and contains $\alpha_1$-adrenergic receptors. Stimulation of these $\alpha_1$-receptors causes the radial muscle to contract, pulling the iris back and dilating the pupil (mydriasis).
14. A 45-year-old patient diagnosed with pheochromocytoma is scheduled for surgical resection. Pre-operative management involves pharmacological stabilization. Administration of a beta-blocker prior to an alpha-blocker is contraindicated because it can lead to a paradoxical hypertensive crisis. Which of the following best explains the mechanism of this adverse event?
    Answer: Unopposed $\alpha_1$-receptor stimulation by endogenous catecholamines leading to severe vasoconstriction. In a patient with pheochromocytoma, there are high levels of circulating epinephrine and norepinephrine. Beta-receptors (especially $\beta_2$) mediate vasodilation in some vascular beds, which partially counteracts the potent vasoconstriction mediated by $\alpha_1$-receptors. If a beta-blocker is given first, it blocks this vasodilatory effect, leaving the $\alpha_1$-mediated vasoconstriction unopposed. This results in a sharp increase in total peripheral resistance and a dangerous hypertensive crisis.
15. The release of insulin from pancreatic beta cells is tightly regulated by autonomic inputs. Sympathetic stimulation generally inhibits insulin release to conserve glucose during stress. This dominant inhibitory effect is mediated by which adrenergic receptor subtype?
    Answer: $\alpha_2$-receptors, via a Gi-mediated inhibition of adenylyl cyclase. Pancreatic beta cells express both $\alpha_2$ and $\beta_2$ adrenergic receptors. Stimulation of $\beta_2$ receptors (Gs-coupled) increases cAMP and promotes insulin release. However, stimulation of $\alpha_2$ receptors (Gi-coupled) inhibits adenylyl cyclase, decreases cAMP, and strongly inhibits insulin release. During a sympathetic surge, the $\alpha_2$-mediated inhibitory effect predominates, leading to a net decrease in insulin secretion.
16. A 68-year-old male with both asthma and hypertension is prescribed a new antihypertensive medication. His physician specifically chose a drug that is a selective $\beta_1$-adrenergic antagonist. This choice was made to minimize adverse effects related to which of the following?
    Answer: Blockade of $\beta_2$-receptors in the bronchi, which could exacerbate asthma. In patients with asthma, maintaining bronchodilation is critical. This is physiologically mediated by $\beta_2$-adrenergic receptors on bronchial smooth muscle. A non-selective beta-blocker would antagonize these $\beta_2$-receptors, leading to bronchoconstriction and worsening of asthma. A selective $\beta_1$-antagonist (cardioselective) is chosen to target $\beta_1$-receptors in the heart and kidney to lower blood pressure, while sparing the $\beta_2$-receptors in the lungs, thus avoiding an asthma exacerbation.
17. A key difference in the cardiovascular profiles of norepinephrine (NE) and epinephrine (Epi) is that at physiological doses, Epi often decreases diastolic blood pressure while NE consistently increases it. This difference arises primarily because:
    Answer: Epi has significantly greater agonist activity at $\beta_2$-receptors than NE. Both norepinephrine and epinephrine are potent agonists at $\alpha_1$ and $\beta_1$ receptors. However, epinephrine is also a potent agonist at $\beta_2$-receptors, whereas norepinephrine has very weak activity at these receptors. The $\beta_2$-mediated vasodilation in skeletal muscle vascular beds caused by epinephrine can lower total peripheral resistance, leading to a decrease in diastolic blood pressure. Since NE lacks this significant $\beta_2$ effect, its powerful $\alpha_1$-mediated vasoconstriction is unopposed, leading to an increase in both systolic and diastolic pressure.
18. A pharmacologist studies sympathetic neurotransmission in an isolated tissue preparation. Application of norepinephrine (NE) is found to inhibit its own subsequent release from nerve terminals upon electrical stimulation. This auto-inhibitory feedback is mediated by NE acting on which presynaptic receptors?
    Answer: Presynaptic $\alpha_2$-receptors, which are coupled to an inhibitory G-protein. Sympathetic nerve terminals possess presynaptic $\alpha_2$-adrenergic receptors that function as autoreceptors. When norepinephrine is released into the synaptic cleft, it can bind to these $\alpha_2$-receptors on the same nerve terminal from which it was released. This binding activates a Gi protein, which inhibits adenylyl cyclase, reduces calcium influx, and ultimately inhibits further exocytosis of norepinephrine-containing vesicles. This constitutes a negative feedback loop.
19. A patient with myasthenia gravis is accidentally given a drug that blocks nicotinic receptors at the neuromuscular junction and also has potent $\alpha_1$-blocking activity. In addition to muscle weakness, which other sign would be most expected?
    Answer: Postural hypotension and dizziness. The question requires identifying the effect of $\alpha_1$-receptor blockade. $\alpha_1$-receptors are located on vascular smooth muscle, where they mediate vasoconstriction to maintain blood pressure, particularly upon standing. Blocking these receptors leads to vasodilation and an inability to constrict veins and arteries appropriately, resulting in orthostatic (postural) hypotension and associated dizziness.

Start this quiz